Laboratory Corp. of America Holdings CEO Adam Schechter's 2021 pay jumps 39% to $21M

Laboratory Corp. of America Holdings reports 2021 executive compensation

By ExecPay News

Published: March 31, 2022

Laboratory Corp. of America Holdings reported fiscal year 2021 executive compensation information on March 31, 2022.
In 2021, five executives at Laboratory Corp. of America Holdings received on average a compensation package of $7.9M, a 39% increase compared to previous year.
Average pay of disclosed executives at Laboratory Corp. of America Holdings
Adam H. Schechter, Chief Executive Officer, received $21M in total, which increased by 39% compared to 2020. 64% of Schechter's compensation, or $13M, was in stock awards. Schechter also received $3.8M in non-equity incentive plan, $1.8M in option awards, $1.3M in salary, as well as $432K in other compensation.
For fiscal year 2021, the median employee pay was $57,614 at Laboratory Corp. of America Holdings. Therefore, the ratio of Adam H. Schechter's pay to the median employee pay was 357 to one.
GLENN A. EISENBERG, Chief Financial Officer, received a compensation package of $6.5M, which increased by 37% compared to previous year. 57% of the compensation package, or $3.7M, was in stock awards.
Paul R. Kirchgraber, Chief Executive Officer, earned $4.4M in 2021, a 49% increase compared to previous year.
Mark S. Schroeder, Executive Vice President, Diagnostics, Laboratory Operations and Global Supply Chain, received $4M in 2021, which increases by 33% compared to 2020.
Brian J. Caveney, Chief Medical Officer, earned $4M in 2021, a 35% increase compared to previous year.

Related executives

Adam Schechter

Laboratory Corp. of America Holdings

Chief Executive Officer

Brian Caveney

Laboratory Corp. of America Holdings

Chief Medical Officer

GLENN EISENBERG

Laboratory Corp. of America Holdings

Chief Financial Officer

Paul Kirchgraber

Laboratory Corp. of America Holdings

Chief Executive Officer

Mark Schroeder

Laboratory Corp. of America Holdings

Executive Vice President, Diagnostics, Laboratory Operations and Global Supply Chain

You may also like

Source: SEC filing on March 31, 2022.